PFS Partners, LLC - ZIOPHARM ONCOLOGY INC ownership

ZIOPHARM ONCOLOGY INC's ticker is ZIOP and the CUSIP is 98973P101. A total of 1 filers reported holding ZIOPHARM ONCOLOGY INC in Q1 2024. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
PFS Partners, LLC ownership history of ZIOPHARM ONCOLOGY INC
ValueSharesWeighting
Q4 2023$71
-46.2%
1,0000.0%0.00%
Q3 2023$132
-74.1%
1,0000.0%0.00%
Q2 2023$510
-19.0%
1,0000.0%0.00%
-100.0%
Q1 2023$630
-3.1%
1,0000.0%0.00%0.0%
Q4 2022$650
-62.2%
1,0000.0%0.00%
-50.0%
Q3 2022$1,720
+38.7%
1,0000.0%0.00%
+100.0%
Q2 2022$1,240
+89.9%
1,0000.0%0.00%0.0%
Q1 2022$653
-40.1%
1,0000.0%0.00%0.0%
Q4 2021$1,0901,0000.00%
Other shareholders
ZIOPHARM ONCOLOGY INC shareholders Q1 2024
NameSharesValueWeighting ↓
MSD Partners, L.P. 15,151,516$49,697,00012.67%
DISCOVERY CAPITAL MANAGEMENT, LLC / CT 9,642,760$31,628,0005.74%
MILLER VALUE PARTNERS, LLC 12,619,730$41,393,0001.84%
MAGNOLIA CAPITAL ADVISORS LLC 90,585$297,0000.38%
Sargent Investment Group, LLC 232,025$759,0000.28%
Old West Investment Management, LLC 210,583$690,0000.20%
Virtus ETF Advisers LLC 112,619$369,0000.18%
tru Independence LLC 213,712$701,0000.10%
AIGEN INVESTMENT MANAGEMENT, LP 180,297$591,0000.08%
Golden State Wealth Management, LLC 90,585$297,0000.08%
View complete list of ZIOPHARM ONCOLOGY INC shareholders